HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447 | -5.9% | 13,647 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $475 | -90.4% | 13,503 | -91.1% | 0.00% | -85.7% |
| Q1 2023 | $4,951 | -56.3% | 151,645 | -26.2% | 0.01% | -56.2% |
| Q4 2022 | $11,326 | -99.9% | 205,550 | +11.7% | 0.02% | +33.3% |
| Q3 2022 | $8,147,000 | +63.2% | 183,941 | +79.7% | 0.01% | +71.4% |
| Q2 2022 | $4,993,000 | +485.3% | 102,376 | +484.1% | 0.01% | +600.0% |
| Q1 2022 | $853,000 | +24.3% | 17,526 | +8.9% | 0.00% | 0.0% |
| Q4 2021 | $686,000 | +11.0% | 16,088 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $618,000 | +13.8% | 16,131 | -16.2% | 0.00% | 0.0% |
| Q2 2021 | $543,000 | +157.3% | 19,251 | +200.8% | 0.00% | – |
| Q1 2021 | $211,000 | +66.1% | 6,400 | +82.9% | 0.00% | – |
| Q4 2020 | $127,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |